Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
NMRA
RLYB
Add up to 3 more stocks
NMRA
Neumora Therapeutics, Inc. Common Stock
-9.08%
$0.48-0.05Delayed quote: Oct 6, 2026, 1:25 PM EDT
Market Cap
$88.49M
52W Range
$0.47 - $3.65
RLYB
Rallybio Corporation
+0.71%
$17.02+0.12Delayed quote: Oct 6, 2026, 1:01 PM EDT
Market Cap
$90.32M
52W Range
$3.67 - $17.57
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | 2.18 |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 1.99 | 0.96 |
| P/S Ratio | N/A | 139.82 |
| P/FCF Ratio | N/A | 3.43 |
| EV/EBITDA | N/A | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 0.0% | 89.3% |
| Operating Margin | 0.0% | -3270.9% |
| Net Margin | 0.0% | 7051.2% |
| ROE | -477.9% | 48.2% |
| ROA | -169.9% | 46.5% |
| ROIC | -216.1% | -24.4% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 4.50 | 27.26 |
| Quick Ratio | 4.50 | 27.26 |
| Debt/Equity | 0.01 | 0.00 |
| Interest Coverage | -74.92 | N/A |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.